Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice  by Komatsu, Masaaki et al.
Homeostatic Levels of p62 Control
Cytoplasmic Inclusion Body Formation
in Autophagy-Deficient Mice
Masaaki Komatsu,1,2,3 Satoshi Waguri,4 Masato Koike,5 Yu-shin Sou,1,2 Takashi Ueno,2 Taichi Hara,6
Noboru Mizushima,6,7 Jun-ichi Iwata,1,2 Junji Ezaki,2 Shigeo Murata,1 Jun Hamazaki,1 Yasumasa Nishito,1
Shun-ichiro Iemura,8 Tohru Natsume,8 Toru Yanagawa,9 Junya Uwayama,9 Eiji Warabi,9 Hiroshi Yoshida,9
Tetsuro Ishii,9 Akira Kobayashi,10 Masayuki Yamamoto,10 Zhenyu Yue,11 Yasuo Uchiyama,5 Eiki Kominami,2
and Keiji Tanaka1,*
1Laboratory of Frontier Science, Tokyo Metropolitan Institute of Medical Science, Bunkyo-ku, Tokyo 113-8613, Japan
2Department of Biochemistry, Juntendo University School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan
3PRESTO, Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan
4Department of Anatomy and Histology, Fukushima Medical University School of Medicine, Hikarigaoka, Fukushima 960-1295,
Japan
5Department of Cell Biology and Neurosciences, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan
6Department of Physiology and Cell Biology, Tokyo Medical and Dental University Graduate School and Faculty of Medicine,
Bunkyo-ku, Tokyo 113-8519, Japan
7SORST, Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan
8National Institutes of Advanced Industrial Science and Technology, Biological Information Research Center (JBIRC),
Kohtoh-ku, Tokyo 135-0064, Japan
9Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tennoudai,
Tsukuba 305-8575, Japan
10Department of Medical Biochemistry and ERATO-JST, Tohoku University Graduate School of Medicine, Aoba-ku,
Sendai 980-8575, Japan
11Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, NY 10029, USA
*Correspondence: tanakak@rinshoken.or.jp
DOI 10.1016/j.cell.2007.10.035SUMMARY
Inactivation of constitutive autophagy results in
formation of cytoplasmic protein inclusions and
leads to liver injury and neurodegeneration, but
the details of abnormalities related to impaired
autophagy are largely unknown. Here we used
mouse genetic analyses to define the roles of
autophagy in the aforementioned events.We re-
port that the ubiquitin- and LC3-binding protein
‘‘p62’’ regulates the formation of protein aggre-
gates and is removed by autophagy. Thus, ge-
netic ablation of p62 suppressed the appear-
ance of ubiquitin-positive protein aggregates
in hepatocytes and neurons, indicating that
p62 plays an important role in inclusion body
formation. Moreover, loss of p62 markedly at-
tenuated liver injury caused by autophagy defi-
ciency, whereas it had little effect on neuronal
degeneration. Our findings highlight the unex-
pected role of homeostatic level of p62, which
is regulated by autophagy, in controlling intra-
cellular inclusion body formation, and indicate
that the pathologic process associated with au-
tophagic deficiency is cell-type specific.Cell 1INTRODUCTION
Macroautophagy (hereafter referred to as autophagy) is
a highly conserved bulk protein degradation pathway in
eukaryotes. In the initial step of this process, the cytoplas-
mic portions and organelles are engulfed within a double-
membrane vesicle called autophagosome, and then the
autophagosome fuses with the lysosomes to degrade
the sequestered materials by various lysosomal hydrolytic
enzymes, followed by generation of amino acids that are
recycled for macromolecular synthesis and energy pro-
duction. Emerging evidence emphasizes the importance
of autophagy in various biological and pathological pro-
cesses, such as cellular remodeling, tumorigenesis, and
developmental programs (Levine and Klionsky, 2004).
Recent evidence indicates that in mammalian cells, au-
tophagy serves two physiological purposes. The first is to
supply amino acids for cell survival under poor environ-
mental conditions, which is universally known as ‘‘adap-
tive autophagy.’’ Indeed, this type of autophagy is rapidly
induced under nutritional deprivation in yeast (Tsukada
and Ohsumi, 1993) and in newborn mice (Kuma et al.,
2004), serving as a basic survival strategy in all eukary-
otes. The second is to degrade proteins in the cell through
continuous operation at a low level irrespective of nutri-
tional stress, known as ‘‘basal or constitutive autophagy.’’
In the latter pathway, autophagy is responsible for the31, 1149–1163, December 14, 2007 ª2007 Elsevier Inc. 1149
turnover of long-lived proteins, disposal of excess (Iwata
et al., 2006) or damaged organelles (Elmore et al., 2001),
and clearance of aggregate-prone proteins (Fortun et al.,
2003; Kamimoto et al., 2006; Ravikumar et al., 2004). Re-
cent genetic studies using mice have highlighted the im-
portance of constitutive autophagy in nondividing cells,
such as hepatocytes and neurons, in which loss of au-
tophagy results in severe liver injury and neurodegenera-
tion, respectively (Hara et al., 2006; Komatsu et al.,
2005, 2006). Unexpected findings in these studies were
that loss of autophagy causes cytoplasmic accumulation
of ubiquitin-positive proteinaceous inclusions, together
with hepatocytic and neuronal death without expression
of proteins with disease-associated mutations (Hara
et al., 2006; Komatsu et al., 2005, 2006). However, the
underlying mechanism of inclusion body formation in the
aforementioned diseases is largely unknown at present.
Using mouse genetics, we report the critical role of the
multifunctional protein ‘‘p62/A170/SQSTM1’’ (also known
as a signaling adaptor/scaffold protein) in the formation of
intracellular ubiquitin-related protein aggregation caused
by deficiency in autophagy. We show that autophagic
degradation of the ‘‘p62’’ via direct interaction with LC3,
a posttranslational modifier essential for autophagosome
formation, prevents inclusion body formation. Importantly,
our studies uncover the molecular mechanism linking au-
tophagy, p62, and inclusion body formation, which is a cel-
lular hallmark in various pathophysiological conditions,
and reveal pathophysiological changes associated with
loss of p62 and/or autophagy in hepatocytes and neurons.
RESULTS
Identification of LC3-Interacting Proteins
The microtubule-associated protein 1A/1B light chain 3
(LC3) is a modifier protein conjugated with phosphatidyl-
ethanolamine (PE), analogous to Atg8 in yeast (Ichimura
et al., 2000). PE-conjugated LC3 (LC3-II) is localized in
the inner and outer membranes of autophagosomes, and
the population associated with the inner membrane is de-
graded after fusion of autophagosomes with lysosomes
(Kabeya et al., 2000). To identify protein(s) that could inter-
act with LC3, we employed the proteomic approach as
described previously (Komatsu et al., 2004) and then
identified a unique protein p62 as one of LC3-interacting
proteins, in addition to LC3-modifying enzymes (Ohsumi,
2001) (Table S1). The p62 protein is conserved in metazoa
and plants but not in yeasts and can bind a large number of
proteins through its multiple protein-protein interaction
motifs (Moscat et al., 2006) (Figure S1). This protein
mediates diverse signaling pathways including cell stress,
survival, and inflammation (Moscat et al., 2006; Wooten
et al., 2006).
p62 Is Degraded by Autophagy-Lysosome
Pathway
To verify the interaction between LC3 and p62 in vivo, we
first carried out immunoprecipitation assay with cultured1150 Cell 131, 1149–1163, December 14, 2007 ª2007 Elsevier Ihepatocytes isolated from green fluorescent protein
(GFP)-LC3 transgenic (Tg) mice (GFP-LC3 tg) (Mizushima
et al., 2004) and confirmed the coimmunoprecipitation of
p62with GFP-LC3 under both nutrient-rich and -poor con-
ditions (Figure 1A).Wealsoconfirmed thecoimmunopreci-
pitation of p62 with endogenous LC3 in wild-type mouse
liver (Figure 1B). In addition to the major band, the minor
band detected by our p62 antibody was probably a p62
splicing variant product found in the mouse protein data-
base or a partially cleaved product (see also Figures 2, 3,
and 4). Moreover, recombinant p62 was pulled down
with recombinant GST-LC3 (Figure 1C), indicating direct
physical interaction between p62 and LC3. Subsequent
binding assays with a series of recombinant p62 mutants
indicated that p62 interacts with LC3 through a linker
region that connects the N-terminal Zinc finger and the
C-terminal ubiquitin-associated (UBA) domain of p62
(Figure S1). Immunofluorescencemicroscopy using hepa-
tocytes isolated from GFP-LC3 Tg mice showed colocali-
zation of large numbers of punctate signal for GFP-LC3
(84.7% ± 10.9%, ± SD, n = 21) with that for p62
(Figure 1E).When autophagosome formation was induced
by nutrient-deprivation, 34.9% ± 6.7% (n = 22) of ring-
shaped GFP-LC3-positive autophagosomes contained
p62 signal, some of which showed partial colocalization
(Figure 1F). A similar colocalization pattern was also ob-
served in liver sections of GFP-LC3 Tg starved for 1 day
(Figure 1G). The p62-positive and GFP-LC3-negative par-
ticles might correspond to late endosomes or lysosomes,
as reported previously (Sanchez et al., 1998). Consistent
with the notion that some population of LC3-II is degraded
in lysosomes (Kabeya et al., 2000), treatment with lyso-
somal enzyme inhibitors, but not with a proteasomal
inhibitor, resulted in the accumulation of LC3-II in primary
hepatocytes (Figure 1D). Similarly, lysosomal inhibition
resulted in marked accumulation of p62 (Figure 1D).
When lysosomal inhibitorswere added to cultured hepato-
cytes, the majority of p62 accumulated around the perinu-
clear region, where it colocalized with the lysosomal
marker LysoTracker (Figure 1H), suggesting the turnover
of p62 together with LC3II in lysosomes.
p62 Is a Component of Inclusions
in Autophagy-Deficient Hepatocytes
If p62 is degraded by the autophagic-lysosome pathway,
autophagy deficiency should result in the accumulation of
p62 protein. To test this in vivo, we used the Atg7F/F:Mx1
mice, in which Atg7, a gene essential for autophagy, can
be depleted in the liver by intraperitoneal injections of pol-
yinosinic acid-polycytidylic acid (pIpC) (Figure 2A, left
panel) (Komatsu et al., 2005). We observed specific accu-
mulation of p62 protein in Atg7-deficient livers (Figures 2A
and 2D) without marked induction of p62 mRNA
(Figure 2E). Similar to Atg7 knockout liver, deficiency of
Atg5, which is essential for autophagosome formation
(Mizushima et al., 2001), was also associated with marked
accumulation of p62 (Figure S2). These results indicate
that p62 turnover is mediated by autophagy. Autophagicnc.
Figure 1. p62 Is Degraded by the Auto-
phagic-Lysosomal Pathway
(A) Interaction of p62 with GFP-LC3. Hepato-
cytes prepared from GFP-LC3 Tg mice were
cultured for 3 hr in Williams’ E medium (lanes
1, 2, and 3) or Hank’s solution (lane 4). The cell
lysates were immunoprecipitated with anti-
Flag or GFP antibodies followed by immuno-
blotting with antibodies against LC3 and p62.
(B) Interaction of p62 with endogenous LC3.
Liver lysates from wild-type mice were immu-
noprecipitated with anti-LC3 antibody or nor-
mal rabbit IgG followed by immunoblotting
with antibodies against LC3 and p62.
(C) In vitro GST pull-down analysis of purified
p62 by recombinant GST or GST-LC3.
(D) Degradation of p62 and LC3. Hepatocytes
prepared from wild-type mice were treated
with E64d (10 mg/ml) and pepstatin A (10 mg/ml)
for 24 hr or lactacystin (10 mM) for 3 hr. The cell
lysates were subjected to SDS-PAGE followed
by immunoblotting with indicated antibodies.
Data shown in (A)–(D) are representative of
three separate experiments.
(E, F, and H) Immunofluorescent analysis of pri-
mary cultured hepatocytes. Hepatocytes iso-
lated from GFP-LC3 Tg mice were cultured for
3 hr in Williams’ E medium (E) and Hank’s solu-
tion (F) or for 24 hr in Williams’ E with E64d and
pepstatin A (H) and then immunostained with
antibody against p62. Lysosomal inhibitor-
treated hepatocytes were stained with the fluo-
rescent acidotropic probe LysoTracker prior to
p62 immunostaining (H). Higher magnification
views are shown in insets. Bar, 10 mm.
(G) Immunofluorescence analysis of the liver of
GFP-LC3 Tg mice. Mice were fasted for 1 day,
and then the liver sectionswere immunostained
with anti-p62 antibody. Right panels show
merged images. Bar, 10 mm.Cell 131, 1149–1163, December 14, 2007 ª2007 Elsevier Inc. 1151
Figure 2. Formation of Ubiquitin- and p62-Positive Inclusions in Autophagy-Deficient Hepatocytes
(A) Accumulation of p62 in Atg7-deficient hepatocytes. Left panel shows liver homogenates from Atg7F/F and Atg7F/F:Mx1 mice at 28-day post-pIpC
injection were subjected to SDS-PAGE followed by immunoblotting with indicated antibodies. Right panel shows liver homogenates were separated1152 Cell 131, 1149–1163, December 14, 2007 ª2007 Elsevier Inc.
breakdown of p62 appears to occur irrespective of cell
type, because a similar observation was recently reported
in HeLa, HEK293T, and mouse embryonic fibroblasts
(Bjorkoy et al., 2005; Wang et al., 2006).
Interestingly, abundant amounts of p62 were noted in
both detergent-soluble and insoluble fractions from
Atg7-deficient livers (Figure 2A, right-middle panel), in par-
allel with accumulation of ubiquitinated proteins in both
fractions from Atg7-deficient but not from control livers
(Figure 2A, right-top panel) (Komatsu et al., 2005). Subse-
quently, to investigate the cellular localization of ubiquitin,
p62, and LC3 in autophagy-deficient hepatocytes, we
generated the Atg7F/F:Mx1:GFP-LC3 mice by crossing
Atg7F/F:Mx1with GFP-LC3 Tgmice. Immunofluorescence
microscopy showed that the Atg7-deficient cultured he-
patocytes contained abundant ubiquitin- (Figure 2B, top
panels), or p62- (Figure 2B, bottom panels) positive inclu-
sions in the cytoplasm, which were also positive for GFP-
LC3. Finally, double immunoelectron microscopy con-
firmed the colocalization of LC3, ubiquitin, and p62
proteins in the cytoplasmic aggregated structures (Figures
2C andS3). Next, we analyzed the inclusion formation pro-
cess. Immunoblot analysis revealed that p62 began to ac-
cumulate in the detergent-soluble fraction at 4 days and
was abundant in both detergent-soluble and -insoluble
fractions at 8 days (Figure 2D). In contrast, RT-PCR anal-
ysis showed no induction of p62 transcript during this pe-
riod (Figure 2E). The accumulation pattern of polyubiquiti-
nated proteins essentially matched that of p62 (Figure 2D).
Double-immunofluorescence microscopy showed the ap-
pearance of ubiquitin- and p62-double-positive dots at 2
days in someAtg7F/F:Mx1 hepatocytes (Figure 2F). At later
stages, both the number of hepatocytes containing the in-
clusions and the size of the inclusions increased gradually
with time. These results suggest the time-dependent de-
velopment of inclusions containing both ubiquitin and
p62 in autophagy-deficient hepatocytes.
p62 Is a Component of Inclusions
in Autophagy-Deficient Neurons
Next, we investigated the behavior of p62 in neuronal-
specific autophagy-deficient mice, Atg7F/F:Nes miceCell 1(Komatsu et al., 2006). Similar to autophagy-deficient
livers, p62 accumulated in themutant brainwithout the ap-
parent induction of itsmRNA (Figures 3A and 3B), implying
a common pathway in p62 turnover across tissues. Fur-
thermore, the p62-positive inclusionswereobserved immu-
nohistochemically in various brain regions in Atg7F/F:Nes
mice (Figure S4). Double-immunofluorescence micros-
copy revealed extensive colocalization of p62 and LC3
(Figure 3C, left panels), or p62 and ubiquitin (Figure 3C,
right panels), in numerous inclusions in the cerebral cor-
tex. Immunoelectron microscopy confirmed the localiza-
tion of p62 in the cytoplasmic aggregated structures (Fig-
ures 3D, top panel, and S5). These inclusions also
contained ubiquitin (Figures 3D, bottom panel, and S5).
Next, we investigated the time course of inclusion forma-
tion in the cerebral cortex of Atg7F/F:Nes mice from 2 to
28 days after birth. Ubiquitin/p62-double-positive dots
began to appear at postnatal day 2 in the cerebral cortex,
and they increased in size and number during postnatal
development (Figure 3E). Taken together, these results
indicate that reduced autophagic activity leads to the for-
mation of ubiquitin- and p62-double positive inclusions in
neurons.
Generation of p62-Knockout Mice
To examine the physiological roles of p62 in autophagy,
we generated p62-knockout (p62/) mice (Figure S6).
They were born at Mendelian frequency, fertile and lived
longer than 1 year (data not shown). Although p62 defi-
ciency was associated with adulthood-onset obesity
and diabetes as reported recently (Rodriguez et al.,
2006), no apparent abnormality was noted in the p62-
deleted liver (Figure S7). Moreover, p62-deficient mice
exhibited neither marked neurodegeneration nor inclu-
sion formation in neurons (see Figures 6 and S8). The
conversion from LC3-I to LC3-II, induction of GFP-LC3
dots, and the appearance of many autophagosome
structures after starvation were similar between the con-
trol and p62-deficient hepatocytes (Figures S9A, S9B,
and S9C). Furthermore, there was no significant change
in the turnover of long-lived protein in the mutant hepato-
cytes (Figure S9D).into detergent (0.5% Tx-100)-soluble (Sol.) and insoluble (Insol.) fractions. Each fraction was subjected to SDS-PAGE and analyzed by immunoblot-
ting with indicated antibodies. Data shown are representative of three separate experiments.
(B) Immunofluorescence analysis of cellular localization of ubiquitin, p62, and LC3 in autophagy-deficient hepatocytes. Hepatocytes isolated from
Atg7F/F:Mx1:GFP-LC3 mice at 14-day post-pIpC injection were immunostained with anti-ubiquitin or p62 antibodies. Right panels show merged
images. Bar, 10 mm.
(C) Immunoelectron micrograph showing double labeling of ubiquitin (10 nm colloidal gold particles [cgp]) and GFP (5 nm cgp), p62 (10 nm cgp), and
GFP (5 nm cgp), or p62 (10 nm cgp) and ubiquitin (5 nm cgp) in hepatocytes isolated from Atg7F/F:Mx1:GFP-LC3 mice at 14-day post-pIpC injection.
Bars, 0.5 mm. Magnified images can be seen in Figure S3.
(D) Immunoblotting analyses of ubiquitinated proteins and p62 in Atg7F/F:Mx1 mice livers at various time points post-pIpC injection. Each fraction
prepared as shown in (A) was subjected to SDS-PAGE and analyzed by immunoblotting with indicated antibodies. Data shown are representative
of three separate experiments.
(E) Quantitation of p62 mRNA level in Atg7F/F:Mx1 liver by RT-PCR. Total RNAs were prepared from Atg7F/F:Mx1 livers at various time points post-
pIpC injection, and then cDNA was synthesized from each RNA, followed by real-time PCR analysis. Data are mean ± standard deviation (SD) values
of p62 mRNA normalized to the amount in Atg7F/F:Mx1 liver at 0 day post-pIpC injection.
(F) Immunohistochemical detection of p62- and ubiquitin-positive inclusions in Atg7-deficient livers. Atg7F/F:Mx1 mice were sacrificed at various time
pointspost-pIpC injection,and liver sectionswere immunostainedwithanti-ubiquitin andp62antibodies.Bottompanels showmerged images.Bar, 10mm.31, 1149–1163, December 14, 2007 ª2007 Elsevier Inc. 1153
Figure 3. Formation of Ubiquitin- and p62-Positive Inclusions in Autophagy-Deficient Neurons
(A) Accumulation of p62 in Atg7-deficient brains. Brain homogenates from Atg7F/F and Atg7F/F:Nes mice at 8 weeks of age were subjected to SDS-
PAGE and analyzed by immunoblotting with indicated antibodies. Data shown are representative of three separate experiments.
(B) Quantitation of p62 mRNA level in Atg7-deficient brains by RT-PCR. Total RNAs were prepared from brains of Atg7F/F and Atg7F/F:Nes mice at 8
weeks of age and analyzed as shown in Figure 2E. Data are mean ± SD values of p62 mRNA normalized to the amount in Atg7F/F brain. The exper-
iments were performed three times.
(C) Immunofluorescence microscopy in Atg7F/F:Nes cerebral cortex. Brain sections of Atg7F/F:Nes mice were immunostained with anti-LC3 and p62
antibodies (left panels) or anti-ubiquitin and p62 antibodies (right panels). Bottom panels show merged images. Bar, 10 mm.
(D) Immunoelectron micrograph showing labeling of p62 (top panel) or double labeling of ubiquitin (10 nm cgp) and p62 (5 nm cgp) in hypothalamic
neurons of 8-week-old Atg7F/F:Nes mice. Bars, 0.5 mm. Magnified images can be seen in Figure S5.1154 Cell 131, 1149–1163, December 14, 2007 ª2007 Elsevier Inc.
Loss of p62 Suppresses Inclusion Formation
in Autophagy-Deficient Hepatocytes
Next, to investigate the roles of p62 in inclusion formation,
we crossed Atg7F/F:Mx1 with p62/ mice, producing
the Atg7- and p62-double knockout (DKO) mice (Atg7F/F:
Mx1:p62/). In contrast to large number of inclusions
positive for ubiquitin in Atg7-deficient hepatocytes, sur-
prisingly such ubiquitin inclusions were almost completely
dispersed in the DKO hepatocytes (Figure 4A). Immuno-
blot analysis revealed that the amounts of accumulated
polyubiquitinated proteins in DKO liver were lower than
those in Atg7-deficient liver. Moreover, the reduction
was more prominent in the insoluble fraction (Figures 4B
and S10A). Interestingly, proteasome function evaluated
by the degradation of polyubiquitinated protein was not
significantly different among the genotypes (Figure S11A).
Furthermore, the degradation of long-lived protein in DKO
hepatocytes was significantly reduced to the levels as
shown in Atg7-deficient hepatocytes (Figure S11C). Elec-
tron microscopic analysis showed that the number of ag-
gregate structures and aberrant concentric membranous
structures that were typical in Atg7-deficient hepatocytes
(Komatsu et al., 2005) were markedly reduced, whereas
smooth endoplasmic reticulum and peroxisomeswere still
abundantly observed in DKO hepatocytes (Figure 4C).
Loss of p62 Suppresses Inclusion Formation
in Autophagy-Deficient Neurons
Wealso examined the roles of p62 in inclusion formation in
autophagy-deficient neurons. As shown in Figure S8,
while no ubiquitin-positive inclusions were detected in
the brains of wild-type and p62-knockout mice, ubiqui-
tin-positive inclusions of various sizes were recognized
immunohistochemically in several regions of the Atg7F/F:
Nes brain. Such inclusions were hardly detected in the
Atg7F/F:Nes:p62/ (DKO) neurons (Figures 4D and S8).
Unlike autophagy-deficient livers, it was difficult to con-
vincingly detect by immunoblot analyses any differences
in the amount of insoluble polyubiquitinated protein be-
tween Atg7- and Atg7/p62-DKO brain (Figures 4E and
S10B). This discrepancy could be due to the relatively
low amounts of insoluble ubiquitinated proteins in total
brain lysates from Atg7F/F:Nes mice, which were insuffi-
cient for the detection of the difference. Actually, the inclu-
sions were observed in some restricted areas such as the
hypothalamus and cerebral cortex, and they were hardly
observed in glial cells (Hara et al., 2006; Komatsu et al.,
2006). Previous electron microscopic analysis showed
that the hypothalamic neurons in Atg7F/F:Nes brain con-
tained large inclusion bodies in the perikarya (Komatsu
et al., 2006). Although such inclusions were hardly de-
tected in the same region of DKO brain, we noticed the
presence of several large neuritic structures with numer-Cellous pleomorphic features of smooth endoplasmic reticu-
lum (Figure 4F; c, e, and f). Similar alteration was also
observed in the Atg7F/F:Nes hypothalamus (Figure 4F,
b and d), but not in the control (Figure 4F, a). In the cere-
bellar nuclei of both Atg7F/F:Nes and DKO brains, which
contained abundant round eosinophilic structures as evi-
dent in hematoxylin and eosin (H&E) stained sections
(Figure 6C, bottom panel), myelinated axons were fre-
quently enlarged and contained aberrant membranous
structures and/or degenerated materials (Figures S12B–
S12F), suggesting axonal degeneration in both Atg7F/F:
Nes and DKO neurons. Taken together, these results
strongly suggest that the inclusion formation but not axo-
nal degeneration is largely dependent on the presence of
p62 in autophagy-deficient neurons.
Liver Injury in Autophagy-Deficient Mice
Is Suppressed by Loss of p62
To examine whether abnormalities in autophagy-deficient
liver are partly caused by the accumulation of p62, we ex-
amined the phenotypes of Atg7F/F:Mx1:p62/ mice. Sur-
prisingly, simultaneous loss of Atg7 and p62 in the liver
significantly suppressed the deleterious phenotypes
caused by ablation of autophagy (Figures 5A and 5B). In-
deed, histological analysis showed hepatocytic hypertro-
phy inAtg7-deficient liver and its suppression in DKO liver.
Accordingly, the hepatic lobular structure was consider-
ably better recognized in DKO than in Atg7-deficient liver
(Figure 5C). While serum levels of aspartate aminotrans-
ferase (AST), alanine aminotransferase (ALT), and alkaline
phosphatase (ALP) were elevated in the DKO mice
compared with the control mice, the levels were markedly
lower than those in single Atg7-deficient mice (Figure 5D).
Almost the same results were observed in Atg7F/F:
Alb:p62/ mice, which exhibited impaired autophagy in
hepatocytes at postnatal stage, without pIpC injection
(Figure S13), indicating that pIpC injection itself does not
affect phenotypes of Atg7F/F:Mx1 or Atg7F/F:Mx1:p62/
mice. Taken together, these results indicate that excess
accumulation of p62 is a major cause of the pathogenic
changes seen in the liver of autophagy-deficient mice.
Ablation of p62 Leads to Neither Improvement
nor Exacerbation of the Phenotypes
in Autophagy-Deficient Neurons
Further, to investigate whether defects in autophagy-defi-
cient brain are also attributed to accumulation of p62
in neurons, we examined the phenotypes of Atg7F/F:
Nes:p62/ mice. In contrast to the recovery of liver injury
in Atg7F/F:Mx1 mice by simultaneous loss of p62, ablation
of p62 did not rescue behavioral abnormalities such as
tremor and abnormal limb clasping recognized in Atg7F/F:
Nes mice (data not shown). Furthermore, histological(E) Appearance of p62- and ubiquitin-positive inclusions in Atg7-deficient cerebral cortex during postnatal (P) development. Atg7F/F:Nes mice were
sacrificed at P2, 5, 11, and 28 days, and the brain sections were immunostained with anti-ubiquitin and p62 antibodies. Bottom panels show merged
images. Bar, 20 mm.131, 1149–1163, December 14, 2007 ª2007 Elsevier Inc. 1155
Figure 4. Indispensable Role of p62 in Inclusion Formation in Autophagy-Deficient Cells
(A) Immunohistochemical analysis of ubiquitin inclusions in Atg7- and Atg7/p62-deficient liver. Liver sections from Atg7F/F:Mx1 and Atg7F/F:
Mx1:p62/ mice at 14-day post-pIpC injection were immunostained with anti-ubiquitin antibody. Bar, 100 mm.
(B) Immunoblotting analysis of Atg7- and Atg7/p62-deficient livers. Liver homogenates from mice of the indicated genotype at 28-day post-pIpC in-
jection were separated into detergent-soluble and insoluble fractions as shown in Figure 2. Each fraction was subjected to SDS-PAGE and analyzed
by immunoblotting with indicated antibodies. Data shown are representative of three separate experiments.
(C) Electron micrographs of control and Atg7/p62-deficient liver. Note that the glycogen area (G), easily observed in control hepatocytes, is markedly
reduced in Atg7/p62-deficient hepatocytes. The boxed region in the top right panel is further magnified in the bottom left panel. Asterisks indicate
regions filled with smooth endoplasmic reticulum. Arrows indicate peroxisomes. Bars, 10 mm (left and right top panels) and 1 mm (left bottom panel).
(D) Immunohistochemical analysis of Atg7- and Atg7/p62-deficient brains. The presence of ubiquitin-positive particles was examined immunohisto-
chemically in the hypothalamic regions of Atg7F/F:Nes and Atg7F/F:Nes:p62/ mice. Bar, 100 mm.
(E) Immunoblotting analysis of Atg7- and Atg7/p62-deficient brains. Brain homogenates frommice of the indicated genotypes at 8 weeks of age were
analyzed by immunoblotting as shown in (B). Data shown are representative of three separate experiments.
(F) Electron micrographs of the hypothalamus of mice of the indicated genotype. Note that several electron-lucent neuritic structures are detected in the
control neuropil (a), which are only rarely seen in the Atg7- (b) andAtg7/p62-deficient (c) tissues. Instead, the latter tissues contain large neurites filled with
pleomorphic featuresof smoothendoplasmic reticulum.Arrows indicateabnormalneuriticstructures, someofwhicharemagnified ind, e,and f.Bars, 1mm.analyses clearly revealed the lack of Purkinje cells in the
cerebellum (Figure 6C) and large pyramidal neurons in
both the cerebral cortex (Figure 6A) and hippocampus
(Figure 6B) of Atg7F/F:Nes:p62/ as well as Atg7F/F:Nes
mice. We also found a number of eosinophilic spheroids in
H&E-stained sections in the cerebellar nuclei of Atg7F/F:
Nes:p62/ mice, similar to Atg7F/F:Nes mice (Figure 6C).
Amarked increase in the number of TUNEL (terminal deox-1156 Cell 131, 1149–1163, December 14, 2007 ª2007 Elsevierynucleotidyl transferase [TdT]-mediated dUTP-biotin nick
end labeling)-positive cells, which were noted in both
Atg7F/F:Nes cerebral cortices and granular cell layers of
the cerebellumatP28, tended todecrease in similar regions
of Atg7F/F:Nes:p62/ mice (Figures 6D and 6E), albeit sta-
tistically insignificant. Thus, these results indicate that abla-
tion of p62 does not result in improvement or exacerbation
of the phenotypes in autophagy-deficient neurons.Inc.
Figure 5. Suppression of Liver Dysfunction in Autophagy-Deficient Mice by Additional Loss of p62
(A) Gross anatomical views of representative livers from mice of the indicated genotype at 28-day post-pIpC injection.
(B) Amount of total liver protein. Livers from mice shown in (A) were dissected out, and amounts of total protein per liver were measured. Data are
mean ± SD values of five mice in each group. *p < 0.05, **p < 0.01, and ***p < 0.001 (Student’s t test).
(C) Typical histology of livers from mice of the indicated genotype. H&E staining of respective livers was conducted at 56-day post-pIpC injection.
Higher magnification views are shown in insets. CV, central vein; P, portal vein. Bar, 100 mm.
(D) Liver function tests of mice shown in (A). Serum levels of AST, ALT, and ALP were measured. Data represent mean ± SD values of seven mice in
each group. *p < 0.05, **p < 0.01, and ***p < 0.001.Aberrant Accumulation of p62 InducesDetoxifying
Enzymes in Livers but Not in Brains
Our data clearly showed that loss of p62 suppresses
liver dysfunction but not neurodegeneration in auto-
phagy-deficient mice. How does p62 function differently
in autophagy-deficient liver and brain? To elucidate the
underlying mechanism for the difference, we examined
gene-expression profiles in autophagy-deficient mice by
microarray analyses and found that detoxifying enzymes
including glutathione S-transferase (GST) families, cyto-
chrome P450 families, and NAD(P)H dehydrogenase
quinone 1 (Nqo1) were highly expressed in the autoph-
agy-deficient liver. However, none of these detoxifyingCelenzymes was upregulated in the autophagy-deficient brain
(Figure 7A). Moreover, such induction in the liver was sup-
pressed almost completely by additional loss of p62
(Figure 7A). As shown in Figure 2D, accumulation and
insolubilizationofbothp62andubiquitinatedproteinsbegan
at 4 days post-pIpC injection in Atg7F/F:Mx1 liver. Further-
more, upregulation of detoxifying enzymes began at
8 days and reached a plateau at 12 days post-pIpC
injection (Figure 7B). Meanwhile, significant leakage of ALT
and AST, representing hepatocyte death, occurred at later
time points (Figure 7C), suggesting that the increase of
detoxifying enzymes was not a secondary effect of liver
dysfunction.l 131, 1149–1163, December 14, 2007 ª2007 Elsevier Inc. 1157
Figure 6. Ablation of p62 Leads to Neither Improvement nor Exacerbation of the Phenotypes in Autophagy-Deficient Neurons
(A and B) H&E staining of the cerebral cortex (A) and pyramidal cell layer of the hippocampus (B) in mice of the indicated genotype at 4 weeks of age.
Top panels in (A) are magnified in bottom panels. Arrows in (A) point to large pyramidal neurons in the cerebral cortex.
(C) Histological analysis of the cerebellar cortex (top and middle panels) and cerebellar nucleus (bottom panel). Cryosections from 8-week-old mice
were stained with H&E (top and bottom panels) or immunostained with Purkinje cell marker, calbindin (middle panels). Bars, 1 mm (A, top panel),
200 mm (C, bottom panel), 100 mm (A, bottom panel), (B and C, top and middle panels).
(D and E) Apoptotic cells in the cerebral cortex (D) and cerebellum (E) at 8 weeks of age of the indicated four genotypes. Bars represent the average
number (±SD) of total TUNEL-positive cells in ten sections counted in three animals for each genotype. *p < 0.05.A key question is how such enzymes are specifically
induced in the autophagy-deficient liver. To this end, we
examined the behavior of the transcriptional factor
‘‘Nrf2,’’ which translocates to the nucleus in response to
oxidative and electrophilic stresses to activate the tran-
scription of various detoxifying enzymes including
Gstm1 and Nqo1 (Tong et al., 2006). As shown in
Figure 7D, the level of Nrf2 was markedly higher in the
nuclear fraction from Atg7F/F:Mx1 liver but very low in
those from control and p62-knockout livers. Importantly,
the translocation of Nrf2 into the nucleus in Atg7F/F:Mx1
liver was almost completely suppressed by additional
loss of p62, implying that autophagy-deficiency causes
cellular stress in the liver, which negatively affects hepa-1158 Cell 131, 1149–1163, December 14, 2007 ª2007 Elsevietocyte function and concomitantly induces p62-depen-
dent activation of Nrf2.
DISCUSSION
p62 Handles Formation of Cytoplasmic Inclusions
While there is ample evidence that dysfunction of the ubiq-
uitin-proteasome system leads to the formation of ubiqui-
tin-positive inclusions, which are the pathological hallmark
of various neurodegenerative diseases (Goldberg, 2003),
suppression of autophagy also leads to the formation of
ubiquitin-positive inclusion (Hara et al., 2006; Komatsu
et al., 2005, 2006). However, the molecular mechanism(s)
involved in the formation of these inclusions is not clear tor Inc.
date. In the present study, we foundmarked accumulation
of p62 and ubiquitinated proteins and subsequent inclu-
sion formation in Atg7-deficient mice (Figures 2 and 3).
Intriguingly, p62 has been identified as amajor component
of ubiquitin-containing inclusions known as the ’’hepato-
cyticMallory body’’ found in alcoholic hepatitis and steato-
hepatitis (Stumptner et al., 2002). Similar inclusions have
been also recognized frequently in proteinaceous aggre-
gates in the remnant neurons in various neurodegenera-
tive disorders such as Parkinson’s disease and amyotro-
phic lateral sclerosis (Kuusisto et al., 2001; Nakano
et al., 2004). In such diseases, it is plausible that the
reduced autophagic activity may be associated with the
generation of inclusion bodies.
Surprisingly, loss of p62 was associated with marked
reduction of ubiquitin-positive inclusions, which were oth-
erwise abundantly present in Atg7-deficient hepatocytes
and neurons (Figure 4). Because ubiquitin-tagged proteins
are sticky but do not exhibit aggregation-prone nature
themselves, the high levels of p62 due to impaired auto-
phagy might predispose to inclusion formation via the
PB1 domain, which retains the ability of self oligomeriza-
tion (Lamark et al., 2003). Indeed, overexpression of p62
forms inclusions, which is dependent on the presence of
both PB1 and UBA domains (Bjorkoy et al., 2005). Since
almost all inclusions in autophagy-deficient cells were
positive for both ubiquitin and p62, it is possible that ubiq-
uitinated proteins initially interact with p62, and subse-
quently the protein complex becomes inclusions in
a p62-dependent manner. Although autophagy is involved
in protection from several discrete diseases (Fortun et al.,
2003; Kamimoto et al., 2006; Ravikumar et al., 2004),
whether p62 is indeed essential for the formation of
disease-related inclusions or not remains unknown at
present. However, intriguingly, the formation of ubiqui-
tin-positive aggregates induced by proteasome inhibition
is greatly suppressed in p62-deficient cells (Wooten et al.,




Our present studies suggest that the pathological changes
in Atg7-deficient liver are due, at least in part, to oxidative
stress associated with proteinaceous aggregates formed
by excess accumulation of p62 and ubiquitinated proteins.
However, emerging evidence indicates that protein aggre-
gates containing disease-relatedproteins (e.g., polyQ) can
provide protection (Arrasate et al., 2004; Ross and Poirier,
2005; Sanchez et al., 2003). Similarly, aggregate formation
mediated by p62 seems to be a protective mechanism in
the presence of overexpression of polyQ (Bjorkoy et al.,
2005). Therefore, p62 might play an important role in the
surveillance of protein abnormalities by adaptively segre-
gating ubiquitin-tagged toxic proteins as inclusions in
cells. It is noteworthy that oligomer and protofibrillar inter-
mediates, which are cytotoxic (Arrasate et al., 2004; Ross
and Poirier, 2005; Sanchez et al., 2003), must form beforeCellthe formation of harmless aggregates and generate reac-
tive oxygen species, which are the primary mediators of
oxidative stress (Tabner et al., 2005). Because genetic
ablation of autophagy in the liver causes exhaustive accu-
mulation of both p62 and ubiquitinated proteins, the liver
might show mixed symptoms related to the cytotoxic
effects and protective reactions—i.e., continuous forma-
tion of both ‘‘harmful oligomer and protofibrillar intermedi-
ates’’ and ‘‘harmless aggregates’’ and induction of both
‘‘oxidative stress’’ and ‘‘detoxifying enzymes.’’ According
to this scenario, simultaneous loss of p62 under auto-
phagy-deficient background might attenuate accumula-
tion of unfavorable harmful oligomer and protofibrillar
intermediates, which ultimately form harmless inclusion,
leading to alleviation of liver injury.
In this context, we found that impairment of liver au-
tophagy led to nuclear translocation of Nrf2 (Figure 7D),
which is responsible for inducible transcription of various
antioxidant and detoxifying enzymes, providing mecha-
nistic insights into the upregulation of those enzymes in
the autophagy-deficient liver. In the absence of stress,
Nrf2 is constitutively degraded through the ubiquitin-pro-
teasome pathway, since the binding partner Keap1 is
a ubiquitin-protein ligase. Exposure to oxidative and elec-
trophilic insults results in modification of Cys residues of
Keap1, and leads to inactivation of Keap1. Stabilization
of Nrf2 leads to its nuclear translocation to induce the
transcription of detoxifying enzymes (Tong et al., 2006).
Accordingly, we surmise that the autophagy-deficient liver
may be filled with oxidative and/or other Nrf2-inducing
stresses. More interestingly, simultaneous loss of p62
and Atg7 completely suppressed the translocation of
Nrf2 (Figure 7D). These results strongly argue for accumu-
lation of cellular stress in autophagy-deficient liver, the
extent of which depends on the impairment of p62 turn-
over, and they shed light on the mechanism of p62 loss-
associated attenuation of autophagy-deficiency-related
liver injury.
On the other hand, leakage of hepatocytic enzymes into
peripheral blood still occurred at a significantly high level
in Atg7F/F:Mx1:p62/ compared with control mice
(Figure 5D), implying other abnormalities apart from p62
accumulation in the DKO livers. In fact, in addition to accu-
mulation of soluble ubiquitinated proteins, impairment of
organelle turnover was not rescued by the additional
defect of p62 (Figures 4B and 4C). Such abnormalities
together with the excess accumulation of p62 might
have irreversible cytotoxic effects in autophagy-deficient
hepatocytes.
p62-Independent Neuronal Death in Autophagy-
Deficient Mice
Unlike the liver, the survival of Atg7-deficient neurons is af-
fected little when p62 is abolished, although p62 can form
protein aggregates in neuronal cells as in hepatocytes.
This paradoxical observation may underlie the difference
inautophagicactivityamongcell-typesor tissues.Thecon-
stitutive autophagic activity in the brain is low compared131, 1149–1163, December 14, 2007 ª2007 Elsevier Inc. 1159
Figure 7. p62-Dependent Induction of Detoxifying Enzymes in Autophagy-Deficient Liver but Not in Brain
(A) Quantitative RT-PCR analyses of Gstm1, Cy2a5, and Nqo1 in mouse liver (top panels) and brain (bottom panels). Total RNAs were prepared from
the livers of the indicated genotypes at 12 days post-pIpC injection and brains of the indicated genotypes at postnatal day 28. The values are nor-
malized to the amount of mRNA in Atg7F/F liver and brain. The experiments were performed three times.
(B) Quantitation of mRNA levels of detoxifying enzymes in Atg7F/F:Mx1 liver by RT-PCR. Total RNAs were prepared from Atg7F/F:Mx1 mice livers at
various time points post-pIpC injection, and then cDNA was synthesized from each RNA, followed by real-time PCR analyses. The values are nor-
malized to the amount of each mRNA in Atg7F/F:Mx1 liver at 0 days post-pIpC injection.
(C) Liver function tests of mice at various time points post-pIpC injection. Serum levels of AST and ALT were measured in Atg7F/F:Mx1 mice. Data
represent two independent mice.1160 Cell 131, 1149–1163, December 14, 2007 ª2007 Elsevier Inc.
with other tissues such as the liver (Mizushima et al., 2004).
Accordingly, significant accumulation of ubiquitinated pro-
teins was noted in Atg7-deficient brain, but their levels, es-
pecially insoluble ubiquitinatedproteins,were lower than in
Atg7-deficient liver (Figures 4E and S10B), and severe for-
mation of the inclusion was found in restricted groups of
neurons (Figures 4D and S8). Moreover, unlike in the liver,
detoxifying enzymes did not increase in Atg7-deficient
brain (Figure 7A), suggesting the low susceptibility of neu-
rons to toxicity associated with aggregate formation. In
fact, several ubiquitin-positive aggregates were recog-
nized in Atg7-deficient brain regions in the presence of
mild neuronal loss (Komatsu et al., 2006).
Why do autophagy-deficient mice develop neurode-
generation? Analyses of Purkinje cell-specific Atg7-
knockout mice demonstrated that Atg7-deficient Purkinje
cells initially causes cell-autonomous, progressive dystro-
phy (manifested by axonal swelling) and degeneration of
the axon terminals followed by cell-autonomous Purkinje
cell death and mouse behavioral deficits (Komatsu et al.,
2007). The mutant Purkinje cells developed aberrant or-
ganelles in the swelling axons, suggesting the important
role of autophagy in the regulation of local axonal mem-
brane trafficking and turnover, and implicate impairment
of axonal autophagy as a mechanism for axonopathy as-
sociated with neurodegeneration. Importantly, such axon-
opathy in Atg7-deficient Purkinje cells and hypothalamic
neuronswas still observed inAtg7/p62-DKO neurons (Fig-
ures 4F, 6C, and S12), indicating that the development of
axonopathy inAtg7-deficient neurons is p62 independent.
Therefore, we hypothesize that the mechanism of neuro-
degeneration caused by autophagy deficiency might
involve distinct pathogenic pathways, such as axonal dys-
trophy and degeneration.
EXPERIMENTAL PROCEDURES
Generation of Knockout Mice
Atg7F/F:Mx1 mice (Komatsu et al., 2005) were bred with GFP-LC3 Tg
mice (Mizushima et al., 2004) to generate Atg7F/F:Mx1:GFP-LC3
mice. p62/ mice were bred with Atg7F/F:Mx1, Atg7F/F:Mx1:GFP-
LC3, and Atg7F/F:Nes mice (Komatsu et al., 2006) to generate Atg7F/F:
Mx1:p62/, Atg7F/F:Mx1:p62/:GFP-LC3, and Atg7F/F:Nes:p62/
mice, respectively. With regard to deletion of Atg7 from the liver, Cre
expression in the liver was induced by intraperitoneal injection of
pIpC (Sigma Chemical Co., St. Louis, MO) (Komatsu et al., 2005).
Mice were housed in specific-pathogen-free facilities, and the experi-
mental protocol was approved by the Ethics ReviewCommittee for An-
imal Experimentation of Tokyo Metropolitan Institute of Medical Sci-
ence. Other mice strains shown in Supplemental Data are described
in Supplemental Experimental Procedures.
Immunological Analysis
Livers and brains were homogenized in 0.25 M sucrose, 10 mM 2-[4-
(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid [HEPES], pH 7.4,
and 1 mM dithiothreitol (DTT). The resultant homogenates were frac-
tionated into 0.5%Tx-100 soluble and insoluble fractions. Immunopre-
cipitation and immunoblot analyses were conducted as described pre-Cellviously (Komatsu et al., 2004). Nuclear fraction from the liver was
prepared according to the method of Blobel and Potter (Blobel and
Potter, 1966). The antibodies for p62, Atg7, and LC3 were described
previously (Ishii et al., 1996; Komatsu et al., 2005). The antibodies for
GFP (Medical and Biological Laboratories [MBL] Co., Nagoya, Japan),
ubiquitin (FK2: MBL), Nrf2 (H-300: Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA), LDH (ab2101: abcam, Inc., Cambridge, MA), actin
(MAB1501R: Chemicon International, Inc., Temecula, CA) and Lamin
B (M-20: Santa Cruz Biotechnology, Inc.) were purchased.
Pull-Down Assay
Recombinant GST, GST-LC3, and GST-p62 were produced in Escher-
ichia coli, and recombinant proteins were purified by chromatography
on glutathione-Sepharose 4B (Amersham Biosciences, Arlington
Heights, IL). The GST-p62 cleaved the GST tag by precision protease
(Amersham Biosciences). Purified p62 and GST or GST-LC3 were
mixed in TNE buffer (Komatsu et al., 2004) for 3 hr at 4C and then pre-
cipitated with glutathione-Sepharose. The mixtures were washed five
times with ice-cold TNE. The bound proteins were analyzed by SDS-
PAGE followed by Coomassie brilliant blue (CBB) staining.
Quantitative RT–PCR
cDNA was synthesized from 1 mg of total RNA using the Transcriptor
First Strand cDNA Synthesis Kit (Roche Applied Science), and quanti-
tative PCR was performed using LightCycler 480 Probes Masterin
(Roche Applied Science) in a LightCycler 480 (Roche Applied Science).
Signals were normalized to b-glucronidase (GUS). Primer sequences
are described in Supplemental Experimental Procedures.
Immunofluorescence Microscopy of Cultured Hepatocytes
Hepatocytes grown on glass coverslips were immunostained with anti-
p62 or ubiquitin (DakoCytomation, Glostrup, Denmark) antibody as
described previously (Komatsu et al., 2005). The coverslips were
mounted and viewed with a laser-scanning confocal microscope
(FV1000, Olympus) or conventional epifluorescent microscope.
Histological Examination
Methods for tissue fixation and subsequent procedures, including H&E
staining, immunohistochemistry, conventional electron microscopy,
immunoelectron microscopy, and TUNEL staining were described
previously (Komatsu et al., 2005, 2006). Antibodies used for immuno-
histochemistry and immunoelectron microscopy were as follows: rab-
bit polyclonal antibodies against LC3 (Komatsu et al., 2005), p62 (Ishii
et al., 1996), and GFP (Abcam), and mouse monoclonal antibodies
against ubiquitin (FK2 and 1B3: MBL).
Statistical Analysis
Data were analyzed by two-tailed Student’s t test. For all graphs, data
are represented as mean ± SD.
Supplemental Data
Supplemental Data include 13 figures, 1 table, Supplemental Experi-
mental Procedures, and Supplemental References and can be found
with this article online at http://www.cell.com/cgi/content/full/131/6/
1149/DC1/.
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